To examine the potential relevance of LXR activation in human CRC, we analysed the expression of CYP27A1, LXR target genes and TLS/B and T cell signatures in a published dataset containing 443 CRC samples divided into six tumour subtypes (c1 to c6)47. This evidence concerns the gene CYP27A1 and neoplasm.